UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment strategies for progressive immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome: case series

Haematologica (Roma), 2024-05

2024

Volltextzugriff (PDF)

Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders

Journal of allergy and clinical immunology, 2022-03, Vol.149 (3), p.1097-1104.e2

2022

Volltextzugriff (PDF)

Gene editing for sickle cell disease and transfusion dependent thalassemias- A cure within reach

Seminars in hematology, 2023-01, Vol.60 (1), p.3-9

2023

Volltextzugriff (PDF)

Parvovirus B19‐associated graft failure after allogeneic hematopoietic stem cell transplantation

Cancer reports, 2022-01, Vol.5 (1), p.e1403-n/a

2022

Volltextzugriff (PDF)

Alternative donor hematopoietic stem cell transplantation for sickle cell disease

Blood advances, 2017-07, Vol.1 (16), p.1215-1223

2017

Volltextzugriff (PDF)

Exagamglogene Autotemcel for Severe Sickle Cell Disease

The New England journal of medicine, 2024-05, Vol.390 (18), p.1649-1662

2024

Volltextzugriff (PDF)

Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies

Journal of allergy and clinical immunology, 2018-12, Vol.142 (6), p.2004-2007

2018

Volltextzugriff (PDF)

Vincristine, irinotecan, and temozolomide for treatment of relapsed alveolar rhabdomyosarcoma

Journal of pediatric hematology/oncology, 2013-05, Vol.35 (4), p.e163-e166

2013

Volltextzugriff (PDF)

Adherence to transcranial Doppler screening guidelines among children with sickle cell disease

Pediatric blood & cancer, 2013-02, Vol.60 (2), p.270-274

2013

Volltextzugriff (PDF)

Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia

American journal of hematology, 2014-02, Vol.89 (2), p.125-129

2014

Volltextzugriff (PDF)

Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance

Transplantation and cellular therapy, 2023-01, Vol.29 (1), p.47.e1-47.e10

2023

Volltextzugriff (PDF)

Chronically Transfused Pediatric Sickle Cell Patients are Protected from Cardiac Iron Overload

Pediatric hematology and oncology, 2012-04, Vol.29 (3), p.254-260

2012

Volltextzugriff (PDF)

A case of pediatric PTLD following autologous stem cell transplantation and review of the literature

Pediatric transplantation, 2012-02, Vol.16 (1), p.E15-E18

2012

Volltextzugriff (PDF)

A unique clinical presentation of X-linked lymphoproliferative syndrome with a novel mutation in SH2D1A and review of the literature

Journal of pediatric hematology/oncology, 2011-01, Vol.33 (1), p.e39-e42

2011

Volltextzugriff (PDF)

Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma

Pediatric blood & cancer, 2009-12, Vol.53 (7), p.1327-1328

2009

Volltextzugriff (PDF)

Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)

Blood, 2020-11, Vol.136 (Supplement 1), p.26-27

2020

Volltextzugriff (PDF)

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

Blood, 2020-11, Vol.136 (Supplement 1), p.36-37

2020

Volltextzugriff (PDF)

Post-Transplant Donor Lymphocyte Infusion with Methotrexate Prophylaxis Is Associated with Low Incidence of Relapse after CD34-Selected, T Cell-Depleted Haploidentical Donor Stem Cell Transplantation Regardless of NK Alloreactivity

Blood, 2015-12, Vol.126 (23), p.3166-3166

2015

Volltextzugriff (PDF)

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC2)

Blood, 2020-11, Vol.136 (Supplement 1), p.8-9

2020

Volltextzugriff (PDF)

Development of a Multi-Center Cohort to Evaluate Long-Term Outcomes and Late Effects Following Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Initiative

Blood, 2017-12, Vol.130, p.3271-3271

2017

Volltextzugriff (PDF)

Successful Virtual Mock FACT Inspection: How Sarah Cannon Blood Cancer Network and Texas Transplant Institute in San Antonio and Austin Made It Work

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S441-S442

2021

Volltextzugriff (PDF)

Prevalence of and Risk Factors for Cardiac, Pulmonary, and Neurologic Dysfunction Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S49-S51

2022

Volltextzugriff (PDF)

58 - Prevalence of and Risk Factors for Cardiac, Pulmonary, and Neurologic Dysfunction Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S49-S51

2022

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(50)
Bücher
(3)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(18)
Hematology
(12)
Child
(9)
Male
(9)
Pediatrics
(9)
Adolescent
(7)
Oncology
(7)
Adult
(5)
Female
(5)
Sickle Cell Disease
(5)
Transplantation
(5)
Anemia, Sickle Cell - Complications
(4)
Autologous Transplant
(4)
Child, Preschool
(4)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(4)
Immunology
(4)
Retrospective Studies
(4)
Anemia, Sickle Cell - Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment strategies for progressive immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome: case series

Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders

Gene editing for sickle cell disease and transfusion dependent thalassemias- A cure within reach

Parvovirus B19‐associated graft failure after allogeneic hematopoietic stem cell transplantation

Alternative donor hematopoietic stem cell transplantation for sickle cell disease

Exagamglogene Autotemcel for Severe Sickle Cell Disease

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies

Vincristine, irinotecan, and temozolomide for treatment of relapsed alveolar rhabdomyosarcoma

Adherence to transcranial Doppler screening guidelines among children with sickle cell disease

Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia

Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance

Chronically Transfused Pediatric Sickle Cell Patients are Protected from Cardiac Iron Overload

A case of pediatric PTLD following autologous stem cell transplantation and review of the literature

A unique clinical presentation of X-linked lymphoproliferative syndrome with a novel mutation in SH2D1A and review of the literature

Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma

Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study

Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

Post-Transplant Donor Lymphocyte Infusion with Methotrexate Prophylaxis Is Associated with Low Incidence of Relapse after CD34-Selected, T Cell-Depleted Haploidentical Donor Stem Cell Transplantation Regardless of NK Alloreactivity

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC2)

Development of a Multi-Center Cohort to Evaluate Long-Term Outcomes and Late Effects Following Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Initiative

Successful Virtual Mock FACT Inspection: How Sarah Cannon Blood Cancer Network and Texas Transplant Institute in San Antonio and Austin Made It Work

Prevalence of and Risk Factors for Cardiac, Pulmonary, and Neurologic Dysfunction Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study

58 - Prevalence of and Risk Factors for Cardiac, Pulmonary, and Neurologic Dysfunction Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study

Suchergebnisse filtern